These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25349681)

  • 1. Cohort profile: golestan hepatitis B cohort study- a prospective long term study in northern iran ​.
    Poustchi H; Katoonizadeh A; Ostovaneh MR; Moossavi S; Sharafkhah M; Esmaili S; Pourshams A; Mohamadkhani A; Besharat S; Merat S; Mohamadnejad M; George J; Malekzadeh R
    Middle East J Dig Dis; 2014 Oct; 6(4):186-94. PubMed ID: 25349681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-familial Transmission of Chronic Hepatitis B Infection: A Large Population-Based Cohort Study in Northern Iran.
    Katoonizadeh A; Motamed-Gorji N; Sharafkhah M; Ostovaneh M; Esmaili S; Eslami L; Gharravi A; Khoshnia M; Shayanrad A; Shakki Katouli F; Shiravi Khuzani A; Amini Kafi-Abad S; Maghsudlu M; George J; Poustchi H; Malekzadeh R
    Arch Iran Med; 2018 Oct; 21(10):436-442. PubMed ID: 30415551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Mutations in the Basal Core Promoter and Pre-core Regions of the Hepatitis B Viral Genome and Longitudinal Changes in HBV Level in HBeAg Negative Individuals: Results From a Cohort Study in Northern Iran.
    Besharat S; Poustchi H; Mohamadkhani A; Katoonizadeh A; Moradi A; Roshandel G; Freedman ND; Malekzadeh R
    Hepat Mon; 2015 Feb; 15(2):e23875. PubMed ID: 25788956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran.
    Roshandel G; Semnani S; Abdolahi N; Besharat S; Keshtkar AA; Joshaqani H; Moradi A; Kalavi K; Jabbari A; Kabir MJ; Hosseini SA; Sedaqat SM; Danesh A; Roshandel D; Hedayat-Mofidi SM
    J Microbiol Immunol Infect; 2008 Jun; 41(3):227-30. PubMed ID: 18629418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis B virus infection in Asian countries.
    Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-Cause and Cause-Specific Mortality in Middle-Aged Individuals with Positive HBsAg: Findings from a Prospective Cohort Study.
    Motamed-Gorji N; Eghtesad S; Sharafkhah M; Masoudi S; Darvishian M; Eslami L; Gharavi A; Khoshnia M; Roshandel G; Shayanrad A; Hariri S; Merat S; Poustchi H; Malekzadeh R
    Arch Iran Med; 2022 Mar; 25(3):139-147. PubMed ID: 35429954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
    Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen-negative chronic infection patients: A population-based prospective cohort.
    Zhu L; Zhai X; Wang Q; Jiang J; Peng H; Song C; Ge Z; Qian J; Zhou M; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhu F
    J Viral Hepat; 2018 Dec; 25(12):1588-1598. PubMed ID: 30112835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and natural course of occult hepatitis B virus infection in residents of 2 communities of Wuwei City, Gansu Province, China.
    Wen X; Su H; Wang Y; Pu Z; Gao J; Ji Z; Yuan X; Li X; Zhang W; Zhang L; Long Y; Yan Y; Shao Z
    J Viral Hepat; 2018 Mar; 25(3):281-288. PubMed ID: 29032635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
    Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
    Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients.
    Degos F; Lugassy C; Degott C; Debure A; Carnot F; Theirs V; Tiollais P; Kreis H; Brechot C
    Gastroenterology; 1988 Jan; 94(1):151-6. PubMed ID: 3275563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.